Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristy P Robledo

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2020
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialGary Wittert, Karen Bracken, Kristy P Robledo, et al.
The Lancet. Child & Adolescent Health|December 13, 2021
Effects of delayed versus immediate umbilical cord clamping in reducing death or major disability at 2 years corrected age among very preterm infants (APTS): a multicentre, randomised clinical trialKristy P Robledo, William O Tarnow-Mordi, Ingrid Rieger, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 10, 2024
Sonothrombolysis Before and After Percutaneous Coronary Intervention Provides the Largest Myocardial Salvage in ST Segment Elevation Myocardial InfarctionPrajith Jeyaprakash, Faraz Pathan, Shanthosh Sivapathan, et al.
BMJ Paediatrics Open|December 11, 2025
Wait a Minute or More (WAMM): a pragmatic stepped wedge cluster randomised implementation trial assessing the effect of a quality improvement programme on the proportion of infants achieving delayed cord clamping more than 60 s in infants <37 weeks' gestation in up to 20 maternity hospitalsHimanshu Popat, Kristy P Robledo, Sarah Finlayson, et al.
European Journal of Endocrinology|December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk modelKristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.
Cancers|January 8, 2023
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)Deborah Smith, Kristy P Robledo, Sonia Yip, et al.
The New England Journal of Medicine|November 1, 2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerPedro T Ramirez, Michael Frumovitz, Rene Pareja, et al.
The Lancet. Oncology|June 6, 2020
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trialMichael Frumovitz, Andreas Obermair, Robert L Coleman, et al.
Gynecologic Oncology|March 25, 2021
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trialMonika Janda, Kristy P Robledo, Val Gebski, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|February 9, 2024
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled TrialMathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2020
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialGary Wittert, Karen Bracken, Kristy P Robledo, et al.
The Lancet. Child & Adolescent Health|December 13, 2021
Effects of delayed versus immediate umbilical cord clamping in reducing death or major disability at 2 years corrected age among very preterm infants (APTS): a multicentre, randomised clinical trialKristy P Robledo, William O Tarnow-Mordi, Ingrid Rieger, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 10, 2024
Sonothrombolysis Before and After Percutaneous Coronary Intervention Provides the Largest Myocardial Salvage in ST Segment Elevation Myocardial InfarctionPrajith Jeyaprakash, Faraz Pathan, Shanthosh Sivapathan, et al.
BMJ Paediatrics Open|December 11, 2025
Wait a Minute or More (WAMM): a pragmatic stepped wedge cluster randomised implementation trial assessing the effect of a quality improvement programme on the proportion of infants achieving delayed cord clamping more than 60 s in infants <37 weeks' gestation in up to 20 maternity hospitalsHimanshu Popat, Kristy P Robledo, Sarah Finlayson, et al.
European Journal of Endocrinology|December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk modelKristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.
Cancers|January 8, 2023
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)Deborah Smith, Kristy P Robledo, Sonia Yip, et al.
The New England Journal of Medicine|November 1, 2018
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerPedro T Ramirez, Michael Frumovitz, Rene Pareja, et al.
The Lancet. Oncology|June 6, 2020
Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trialMichael Frumovitz, Andreas Obermair, Robert L Coleman, et al.
Gynecologic Oncology|March 25, 2021
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trialMonika Janda, Kristy P Robledo, Val Gebski, et al.
Pageof 6